Triple-negative breast cancer (TNBC) characterizes breast cancers with a lack of estrogen/progesterone receptors and human epidermal growth factor receptor 2 (HER2), making it more difficult to treat than estrogen receptor positive (ER+) breast cancers [1]. Here, ESR1 is linked to triple-negative breast carcinoma.